Natco Pharma Limited announced that the Board of Directors of the company at its meeting held on February 11, 2015, has appointed Dr. M. U. R. Naidu as Additional Director of the company and Dr. D. Linga Rao, President (Technical Affairs) as Additional Director of the company who will be in the whole time employment of the company and be designated as Director & President (Technical Affairs).
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,003 INR | +0.40% | +2.06% | +23.63% |
May. 08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
May. 08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.63% | 2.15B | |
+37.78% | 723B | |
+32.82% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.64% | 244B | |
-4.13% | 208B | |
+10.63% | 210B | |
+9.32% | 169B |
- Stock Market
- Equities
- NATCOPHARM Stock
- News NATCO Pharma Limited
- Natco Pharma Limited Announces Board Appointments